A case of peplomycin-induced scleroderma [2]

British Journal of Dermatology

Volumn 150, Issue 6, 2004, Pages 1213-1214

  Asano, Y ^a   Ihn, H ^a   Shikada, J ^a   Kadono, T ^a   Kikuchi, K ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPLEOMYCIN; PREDNISONE;

AGED; ANAMNESIS; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; EDEMA; HUMAN; LABORATORY TEST; LETTER; LIP CARCINOMA; MALE; MUSCLE STRENGTH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA;

AGED; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; HUMANS; LIP NEOPLASMS; MALE; PEPLOMYCIN; SCLERODERMA, DIFFUSE;

EID: 3142723178     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05969.x     Document Type: Letter

References (11)

1. Finch WR, Rodnan GP, Buckingham RB et al. Bleomycin-induced scleroderma. J Rheumatol 1980; 7: 651-9.
2. Kerr LD, Spiera H. Scleroderma in association with the use of bleomycin: a report of 3 cases. J Rheumatol 1992; 19: 294-6.
3. Kim KH, Yoon TJ, Oh CW et al. A case of bleomycin-induced scleroderma. J Korean Med Sci 1996; 11: 454-6.
4. Bork K, Korting GW. Symptomatic scleroderma caused by bleomycin. Hautarzt 1983; 34: 10-12.
5. Behrens S, Reuther T, von Kobyletzki G et al. Bleomycin-induced PSS-like pseudoscleroderma. Case report and review of the literature. Hautarzt 1998; 49: 725-9.
6. Matsuda A, Yoshioka O, Yamashita T et al. Fundamental and clinical studies on new bleomycin analogs. Recent Results Cancer Res 1978; 63: 191-210.
7. Clark JC, Starcher BC, Uitto J. Bleomycin-induced synthesis of type I procollagen by human lung and skin fibroblasts in culture. Biochem Biophys Acta 1980; 631: 359-70.
8. King SL, Lichtler AC, Rowe DW et al. Bleomycin stimulates pro α(I) collagen promoter through transforming growth factor-β response element by intracellular and extracellular signaling. J Biol Chem 1994; 269: 13156-61.
9. Ueta E, Osaki T, Yoneda K, Yamamoto T. Upregulation of respiratory burst of polymorphonuclear leukocytes by a bleomycin derivative, peplomycin. Free Radic Res 1995; 22: 533-44.
10. Ichihashi M, Shinkai H, Takei M, Sano S. Analysis of the mechanism of bleomycin-induced cutaneous fibrosis in mice. J Antibiot 1973; 106: 238-42.
11. Ishizuka M, Takayama H, Takeuchi T. Activity and toxicity of bleomycin. J Antibiot 1967; 20: 15-24.